Cited by 501Immune cells in cancerAngiogenesis and VEGF in CancerCancer, Stress, Anesthesia, and Immune Response

New insights into M1/M2 macrophages: key modulators in cancer progression

Open access
Liu, Jiuyang, Geng, Xiafei, Hou, Jinxuan, Wu, Gaosong·2021·Cancer Cell International

Abstract

Infiltration of macrophages in and around tumor nest represents one of the most crucial hallmarks during tumor progression. The mutual interactions with tumor cells and stromal microenvironment contribute to phenotypically polarization of tumor associated macrophages. Macrophages consist of at least two subgroups, M1 and M2. M1 phenotype macrophages are tumor-resistant due to intrinsic phagocytosis and enhanced antitumor inflammatory reactions. Contrastingly, M2 are endowed with a repertoire of tumor-promoting capabilities involving immuno-suppression, angiogenesis and neovascularization, as well as stromal activation and remodeling. The functional signature of M2 incorporates location-related, mutually connected, and cascade-like reactions, thereby accelerating paces of tumor aggressiveness and metastasis. In this review, mechanisms underlying the distinct functional characterization of M1 and M2 macrophages are demonstrated to make sense of M1 and M2 as key regulators during cancer progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12935-021-02089-2

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • M1 macrophages secrete CXCL9, CXCL10 and CXCL15 chemokines upon STAT1 signaling, which recruit cytotoxic T lymphocytes (CTLs) to the tumor.

    “In addition, M1 macrophages secrete CXCL9, CXCL10 and CXCL15 chemokines upon STAT1 signaling, which recruit cytotoxic T lymphocytes (CTLs) to the tumor (43).”

    From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [43]

    The Introduction’s “Major functional properties of M1 phenotype” section says M1 macrophages can strengthen CD8+ T-cell cytotoxic functions through IL-6, IL-12 and TNF. It does not say they secrete CXCL9, CXCL10 or CXCL15 upon STAT1 signaling, or that those chemokines recruit CTLs to tumors; searches for the chemokines and STAT1 found no supporting passage. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Authors
Liu, J., Geng, X., Hou, J., & Wu, G.
Affiliations
Zhongnan Hospital of Wuhan University (CN)
Corresponding author
  • Hou, Jinxuan
  • Wu, Gaosong
Venue
Cancer Cell International
Published
2021-07-21
Volume
21
Issue
1
Pages
389-389
ISSN
1475-2867 (ISSN-L)
OpenAlex
W3183953302
Cited by
501
References
60
Citations by year
2026: 69 · 2025: 130 · 2024: 119 · 2023: 117 · 2022: 59 · 2021: 7
FWCI
7.91
Type
journal article
Language
en
Open access
Locations
  • Cancer Cell International (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Construction of Advantage Disciplines in Zhongnan Hospital of Wuhan University (XKJS202015)
  • Improving the Ability of Diagnosis and Treatment of Difficult Diseases (Oncology) Registered Clinical Project of Zhongnan Hospital of Wuhan University (ZLYNXM202014)
  • Fundamental Research Funds for Central Universities of the Central South University (2042019kf0141)
  • Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (WJ2019H015)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Psychiatry and Mental health › Cancer, Stress, Anesthesia, and Immune Response
Keywords
M1 macrophages, M2 macrophages, tumor-associated macrophages, macrophage polarization, tumor progression, tumor microenvironment, immunosuppression, angiogenesis, metastasis, stromal remodeling, phagocytosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review